- HOME
- Products & Services
- Modified Oligonucleotide Synthesis
Modified Oligonucleotide Synthesis
Product Features
1. Seamless synthesis from small to large scale (µg–g range)
We offer flexible synthesis services, covering a wide range from small-scale (µg level) to large-scale (mg–g level) production.
2. Custom oligo synthesis using your own amidites
We can manufacture custom oligonucleotides using amidites you provide, including commercially available ones.
Before synthesis, we will work together with you to discuss and refine the production plan, ensuring careful communication and regular progress updates throughout the process.
Please feel free to contact us for details.
3. Extensive optional services
A variety of optional services are available to meet your specific needs, including in vivo grade products.
For more details, please visit our Optional Services page.
4. Wide selection of 63 modifications
We currently offer 63 types of modifications, with additional variations to be added in the future.
If you are looking for a modification that is not listed, we are happy to discuss custom modifications to meet your needs.
Our technical support team is ready to assist with your inquiries and requests — Please feel free to contact us anytime.
In the list below, you can click on each modification name to view its chemical structure.
Extensive experience in manufacturing ASOs, dsRNAs, aptamers, etc.
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 1 | Phosphorothioate (PS) | ✓ *1 | ✓ | ✓ *1 | ✓ | ✓ |
| 2 | 2′-MOE | ✓ | ✓ | ✓ | ✓ | ✓ |
| 3 | 2′-F | ✓ | ✓ | ✓ | ✓ | ✓ |
| 4 | 2′-OMe | ✓ | ✓ | ✓ | ✓ | ✓ |
| 5 | 5-Methyl-dC | ✓ | ✓ | ✓ | ✓ | ✓ |
| 6 | Locked Nucleic Acid |
✓ | ✓ | ✓ | ✓ | ✓ |
| 7 | Acyclic Nucleic Acid (SNA) | ✓ | ✓ | ✓ | – | ✓ |
| 8 | Acyclic Nucleic Acid (iL-aTNA) *2 |
✓ | ✓ | ✓ | – | ✓ |
- *1 PS linkage can be inserted between the 5′ or 3′ modification and the oligonucleotide backbone.
- *2 Available only under an agreement with Nagoya University. For inquiries, please contact us here.
Tri-GalNAc conjugation is utilized in seven approved oligonucleotide therapeutics, including Givlaari, Oxlumo, Leqvio, Amvuttra, Qfitlia, Wainua, and Tryngolza.
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 9 | Tri-GalNAc 【NEW】 | – | – | ✓ | – | ✓ |
| 10 | dR-GalNAc | ✓ | ✓ | ✓ | – | ✓ |
| 11 | GalNAc〈C3〉 | ✓ | ✓ | ✓ | – | ✓ |
| 12 | Cholesterol〈TEG〉 | ✓ | – | ✓ | – | ✓ |
| 13 | Tocopherol〈TEG〉 | ✓ | – | – | ✓ | ✓ |
Unmodified oligonucleotides from chemical synthesis have a 5’OH group.
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 14 | 5′Phosphate | ✓ | – | – | ✓ (RNA×) | ✓ |
| 15 | 5′Vinyl Phosphonate, 2′-OMe-U (5′VP)【NEW】 | ✓ | – | – | – | ✓ |
Also applicable as probes for virus detection and other diagnostic purposes.
| No. | Modification | Position | Purification | λabs (nm) | λem (nm) | Compatible Quenchers | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | |||||
| 16 | Fluorescein (6-FAM) | ✓ | ✓ *3 | ✓ | – *4 | ✓ | 494 | 525 | Dabcyl TAMRA BHQ-1 |
| 17 | Cyanine3 | ✓ | – | ✓ | – | ✓ | 552 | 565 | BHQ-1 BHQ-2 |
| 18 | TAMRA | ✓ | ✓ *3 | ✓ | – | ✓ | 555 | 580 | BHQ-1 BHQ-2 |
| 19 | Rhodamine (ROX) | ✓ | ✓ *3 | ✓ | – | ✓ | 568 | 595 | BHQ-2 |
| 20 | Cyanine5 | ✓ | – | ✓ | – | ✓ | 650 | 667 | BHQ-2 BHQ-3 |
| 21 | BHQ-1 | – | – | ✓ | – | ✓ | 534 | – | – |
| 22 | BHQ-2 | – | – | ✓ | – | ✓ | 579 | – | – |
| 23 | BHQ-3 | – | – | ✓ | – | ✓ | 672 | – | – |
| 24 | Dabcyl *5 | – | – | ✓ | – | ✓ | 453 | – | – |
| 25 | Real-Time PCR Probe *6 | – | – | – | – | ✓ | – | – | – |
- *3 Attached to dT via an amino linker.
- *4 Cartridge purification is also available for 3′ or internal labeling.
- *5 Ideal for molecular beacon applications.
- *6 Catalog product (5′FAM-DNA-3′TAMRA) available for 11–30 mer oligos.

ATTO-TEC series covers a wide spectral range from visible to near-infrared (390–740 nm) and can also be used as alternatives to various other fluorescent dyes.
| No. | Modification | Position | Purification | λabs (nm) | λem (nm) | Compatible Quenchers | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | |||||
| 26 | ATTO 【NEW】 | ✓ | – | ✓ | – | ✓ | ATTO-TEC Series List (PDF) | ||
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 27 | Biotin〈standard〉 | ✓ | ✓ *3 | – | ✓ | ✓ |
| 28 | Biotin〈TEG〉 | ✓ | – | ✓ | ✓ | ✓ |
| 29 | DIG | ✓ | ✓ *3 | ✓ | – | ✓ |
- *3 Attached to dT via an amino linker.
| No. | Modification | Position | Purification | Reaction Partner | Reaction Name | Catalyst | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | |||||
| 30 | Amino Modifier〈C6〉 | ✓ | – | ✓ | ✓ | ✓ | NHS Ester | Amide Bond Formation | Not Required |
| 31 | Amino-dT〈C6〉 | ✓ | ✓ | ✓ | ✓ | ✓ | NHS Ester | Amide Bond Formation | Not Required |
| 32 | EC Amino Linker | ✓ | – | – | ✓ | ✓ | NHS Ester | Amide Bond Formation | Not Required |
| 33 | Thiol *7 | ✓ | – | ✓ | – | ✓ | Maleimide | Michael Addition | Not Required |
| 34 | Azide | ✓ | ✓ *3 | ✓ | – | ✓ | Alkyne | Click Chemistry | Cu2+ *8 |
| 35 | Alkynyl | ✓ | ✓ *3 | ✓ | – | ✓ | Azide | Click Chemistry | Cu2+ |
| 36 | DBCO〈TEG〉 | ✓ | – | – | – | ✓ | Azide | Click Chemistry | Not Required |
- *3 Attached to dT via an amino linker.
- *7 The 5′ modification has a C6 spacer and the 3′ modification has a C3 spacer.
- *8 No catalyst is required when the counterpart is DBCO.
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 37 | 3′Phosphate | – | – | ✓ | ✓ | ✓ |
| 38 | 2′,3′-ddC | – | – | ✓ | ✓ | ✓ |
| 39 | idT | – | – | ✓ | ✓ | ✓ |
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 40 | Spacer C3 | ✓ | ✓ | ✓ | ✓ | ✓ |
| 41 | Spacer 9 | ✓ | ✓ | ✓ | ✓ | ✓ |
| 42 | Spacer C12 | ✓ | ✓ | ✓ | ✓ | ✓ |
| 43 | Spacer 18 | ✓ | ✓ | ✓ | ✓ | ✓ |
| 44 | d-Spacer | ✓ | ✓ | ✓ | ✓ | ✓ |
| 45 | r-Spacer | ✓ | ✓ | ✓ | ✓ | ✓ |
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 46 | deoxyInosine (dI) | ✓ | ✓ | ✓ | ✓ | ✓ |
| 47 | deoxyUridine (dU) | ✓ | ✓ | ✓ | ✓ | ✓ |
| 48 | 5-hydroxymethyl-dC | ✓ | ✓ | ✓ | ✓ | ✓ |
| 49 | N6-Me-dA | ✓ | ✓ | ✓ | ✓ | ✓ |
| 50 | 8-oxo-dG | ✓ | ✓ | ✓ | – | ✓ |
| 51 | 8-oxo-dA | ✓ | ✓ | ✓ | – | ✓ |
| 52 | 5-Bromo-dU | ✓ | ✓ | ✓ | ✓ | ✓ |
| 53 | 8-Bromo-dA | ✓ | ✓ | ✓ | ✓ | ✓ |
| 54 | pseudo-dU | ✓ | ✓ | ✓ | ✓ | ✓ |
| 55 | 8-Amino-dA | ✓ | ✓ | ✓ | ✓ | ✓ |
| 56 | Reverse (Inverse) -Abasic | ✓ | ✓ | ✓ | ✓ | ✓ |
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 57 | riboInosine (rI) | ✓ | ✓ | ✓ | ✓ | ✓ |
| 58 | 5-Methyl-rU (rT) | ✓ | ✓ | ✓ | ✓ | ✓ |
| 59 | pseudo-rU | ✓ | ✓ | ✓ | ✓ | ✓ |
| 60 | 2,6-diaminopurine (DAP) | ✓ | ✓ | ✓ | – | ✓ |
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 61 | puromycin | – | – | ✓ | ✓ | ✓ |
| No. | Modification | Position | Purification | |||
| 5′ | Internal | 3′ | Cartridge | HPLC | ||
| 62 | CNV-K | ✓ | ✓ | ✓ | ✓ | ✓ |
| 63 | CNV-D | ✓ | ✓ | ✓ | ✓ | ✓ |
We also offer synthesis of various other modified oligonucleotides.
Phosphorodithioate (PS2), 1-Methyl-rA (m1A), 5-Methyl-rC (m5C), N6-Me-rA (m6A), 4-thio-rU (s4U) and others
Workflow - From Order to Delivery

We will send an Order Confirmation Notice by e-mail, so please make sure to review the order details (such as purification method, sequence, etc.).
1. Place your order via our website or by e-mail.
2. After receiving your order, we will inform you of the estimated delivery schedule by e-mail.
3. Synthesis of your oligonucleotide will begin, followed by a thorough quality inspection.
4. Prior to shipment, we conduct final quality checks and deliver only products that have passed our quality standards.
Order Acceptance and Shipping Information
| Order cutoff time | Mon–Sat | E-mail / Web: by 16:00 | |
| Shipping | Mon–Sat | In operation | |
| Sun & Holidays | Closed | ||
| Delivery | Mon–Fri | For inquiries, please use our inquiry form. |
